首页 › 基金 › ADAR1 Capital Management, LLC › VKTX

ADAR1 Capital Management, LLC 对 VKTX 的持仓历史

VIKING THERAPEUTICS INC · 医疗保健

ADAR1 Capital Management, LLC 在 Q3 2026 的 13F 申报中披露持有 VKTX(VIKING THERAPEUTICS INC)100,000 股,市值约 US$10.0M,约占其申报组合的 0.55%,在其申报持仓中市值排名第 50 位。 ADAR1 Capital Management, LLC 最近 12 个申报季度中有 12 个季度披露了 VKTX 持仓,最早可追溯至 Q4 2023。

最新持仓 (Q3 2026)100.00K 股
申报持仓市值$9.95M
组合权重0.55%
首次申报Q4 2023
最近变动减持
更新于2026-11-16

最后更新: 2026-11-16 · 来源: SEC EDGAR Form 13F-HR

ADAR1 Capital Management, LLC 对 VKTX 的持仓演变

ADAR1 Capital Management, LLC 于 Q4 2023 首次披露 VKTX 持仓:254,151 股(约 US$4.7M)。 该持仓在 Q2 2026 达到峰值 574,038 股,市值约 US$22.4M。 在 12 次申报中,ADAR1 Capital Management, LLC 7 次增持、4 次减持、0 次保持不变。 最近一期申报(Q3 2026)显示持股 100,000 股、市值约 US$10.0M,环比减持 -474,038 股。。 持仓曾出现大幅变动:Q2 2024 增持约 533% (随后一个季度股价上涨 19%)、Q1 2025 增持约 539% (随后一个季度股价上涨 10%)、Q1 2026 增持约 760% (随后一个季度股价上涨 20%)。

逐季持仓明细

季度股数金额变化
Q4 2023 254.15K $4.73M 新进
Q1 2024 14.40K $1.18M 减持
Q2 2024 91.23K $4.84M 增持
Q3 2024 7.10K $449.50K 减持
Q4 2024 9.30K $374.23K 增持
Q1 2025 59.41K $1.43M 增持
Q2 2025 67.81K $1.80M 增持
Q3 2025 175.92K $4.62M 增持
Q4 2025 26.49K $932.06K 减持
Q1 2026 227.72K $7.41M 增持
Q2 2026 574.04K $22.39M 增持
Q3 2026 100.00K $9.95M 减持

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 VKTX 与 13F 数据

VKTX(VIKING THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 28 只申报持有 VKTX,申报仓位最大的包括:Context Capital Management, LLC (US$39.9M), Eversept Partners, LP (US$32.8M), Vestal Point Capital, LP (US$26.5M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 VKTX 的基金

查看 VKTX 的全部基金持有人 →

常见问题

How long has ADAR1 Capital Management, LLC held VKTX?

ADAR1 Capital Management, LLC has disclosed VKTX holdings in 12 of the last 12 reported quarters, going back to Q4 2023.

What is ADAR1 Capital Management, LLC's current position in VKTX?

As of Q3 2026, ADAR1 Capital Management, LLC holds 100.00K shares of VKTX (VIKING THERAPEUTICS INC), valued at $9.95M, representing 0.55% of its reported portfolio and ranking #50.

Has ADAR1 Capital Management, LLC been buying or selling VKTX?

In the latest 13F filing (Q3 2026), ADAR1 Capital Management, LLC reduced its position in VKTX. The position peaked in Q2 2026 at 574.04K shares.

Which other funds hold VKTX?

Other major institutional holders of VKTX include Context Capital Management, LLC, Eversept Partners, LP, Vestal Point Capital, LP, among 28 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.